US company Novavax is one in the race to develop a vaccine for COVID-19
Reports the US Department of Defense have granted the company a contract as part of the development
Background to this is that Novavax was one of the first vaccine developers to announce a candidate for the coronavirus.
- company has said it aims to produce 100 million doses by the end of the year
- Novavax began clinical trials of its coronavirus vaccine candidate in Australia in May.
- Initial results from those trials are expected in July.
